Sanyan Bio
Latest round
- Series A
Last raised
- Apr 2026
Total raised
- $1.5M
Investors
- 1
About Sanyan Bio
, dba Sanyan Bio, is a synthetic biotechnology company focusing on the R&D of extracellular matrix (ECM) efficacy raw materials., leveraging its high-level expression system and AI-assisted protein design platform, develops core efficacy raw materials, including recombinant human elastin, recombinant human fibronectin, recombinant human copper-zinc superoxide dismutase (Cu/Zn-SOD), and ultra-small molecule sodium hyaluronate. The materials are applied in the medical aesthetics field for anti-aging repair, tissue regeneration, deep moisturizing, and anti-oxidation. The company generates revenue from developing and providing medical aesthetics and health-related raw materials., upgrade AI-driven synthetic biology technology platform, and accelerate the R&D and registration application of multiple medical aesthetic pipeline products in the field of ECM.
Who invested in Sanyan Bio
1 investor across 1 round
See all investors in Sanyan Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 30, 2026
Amount
$1.5M
Investors
Questions about Sanyan Bio
Who invested in Sanyan Bio?
Sanyan Bio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sanyan Bio raised?
Sanyan Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Sanyan Bio last raise money?
Sanyan Bio's most recent round on record is a Series A, in Apr 2026.
What does Sanyan Bio do?
, dba Sanyan Bio, is a synthetic biotechnology company focusing on the R&D of extracellular matrix (ECM) efficacy raw materials.
Where is Sanyan Bio headquartered?
Sanyan Bio is headquartered in Hangzhou, China.
Which VCs invest in companies like Sanyan Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Sanyan Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Sanyan Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.